FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

9539011000001108: Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31105901000001118 Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
95795701000001117 Boots Mucus Cough Relief 100mg/5ml oral solution (The Boots Company Plc) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Is a Guaifenesin 100mg/5ml oral solution true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Has active ingredient Guaifenesin true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Has manufactured dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Is a Nirolex Chesty Cough false Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Has specific active ingredient Guaifenesin true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Has manufactured dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Is pack of False Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Has AMP True Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start